Skip to main content

Table 5 Comparison of treatment outcome of active and subclinical tuberculosis diseases among the drug-susceptible cohort

From: Clinical profiles of subclinical disease among pulmonary tuberculosis patients: a prospective cohort study in South Korea

 

Active TB disease (n = 308)

Subclinical TB disease (n = 75)

p value

Mortalitya

 Number (%)

26 (8.4%)

1 (1.3%)

0.031e

 OR (95% CI)

Reference

0.15 (0.02–1.10)

0.054

 Adjusted ORd (95% CI)

Reference

0.21 (0.03–1.61)

0.123

Treatment successb

 Number (%)

252 (81.8%)

67 (89.3%)

0.118e

 OR (95% CI)

Reference

0.54 (0.24–1.18)

0.122

 Adjusted ORd (95% CI)

Reference

0.63 (0.28–1.41)

0.259

Favourable outcomec

 Number (%)

246 (79.9%)

67 (89.3%)

0.057e

 OR (95% CI)

Reference

0.47 (0.21–1.04)

0.062

 Adjusted ORd (95% CI)

Reference

0.53 (0.24–1.18)

0.122

  1. TB tuberculosis, OR odds ratio, CI confidence interval
  2. aIncidence of mortality during or before anti-TB treatment
  3. bSum of cured and treatment completed cases within 1 year of anti-TB treatment
  4. cSum of treatment success and no recurrence
  5. dAdjusted by age and gender
  6. eChi-square test
Back to article page

BMC Pulmonary Medicine

ISSN: 1471-2466

Contact us